Our Story

Founded as a University of Oxford spinout by leading academics, including Oxford Professor of Stroke Medicine Alastair Buchan.

Brainomix pioneers the world's first fully automated AI-imaging tool with the launch of e-ASPECTS.

A partnership with the Angels Initiative signifies the first of many strategic partnerships for Brainomix.

Brainomix 360 Mobile launches, connecting stroke networks and enabling real-time results on iOS and Android.

Brainomix is awarded a prestigious NHS AI grant that will result in the largest real-world evaluation of stroke AI and a subsequent Lancet Digital Health publication.

National deployments of Brainomix 360 Stroke across Hungary and Wales firmly establish Brainomix as the European market leader.

With the introduction of e-MRI, Brainomix 360 Stroke continues to expand its capabilities and provide clinicians with the most comprehensive stroke AI platform.

Brainomix 360 Stroke launches in the US, supporting imaging-based treatment decisions at all points across the stroke pathway.

e-Lung is FDA cleared and formally launches in the US. The AI imaging platform automatically identifies and quantifies features on CT lung scans.

The largest real-world evaluation of stroke AI is published in Lancet Digital Health, validating Brainomix 360 Stroke's impact on stroke treatment with a demonstrated 100% increase in thrombectomy rates.

Brainomix 360 Stroke Next Generation is awarded the prestigious Red Dot Design Award, in recognition of the technology's excellence in usability, safety and innovative design.